Install
News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals
- 37articles · 30d
- 9+ hour agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 132avg words
- Medical 32
- Health & Wellness 28
- Health 26
- Business & Industrial 9
- Economy, Business & Finance 4
- Finance & Business 4
- Science & Technology 4
- Human Interest 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
10+ hour, 7+ min ago (124+ words) PharmaDispatch FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making it the first FDA-sanctioned imaging agent for glioma, the…...
Australian biotech Immuron takes gut health treatment to the US market - BioPharmaDispatch
1+ week, 12+ hour ago (121+ words) Australian biotech Immuron takes gut health treatment to the US market PharmaDispatch Australian biotech Immuron takes gut health treatment to the US market Melbourne-based Immuron is preparing to bring its digestive health product PROIBS to American shelves after striking an…...
Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage - BioPharmaDispatch
1+ week, 12+ hour ago (124+ words) Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage PharmaDispatch Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage Neurizon Therapeutics, the Melbourne-based biotechnology company developing…...
Alterity secures option underwriting as it prepares for pivotal MSA trial
2+ week, 11+ hour ago (140+ words) PharmaDispatch Alterity secures option underwriting as it prepares for pivotal MSA trial Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of…...
Sandoz earns workplace recognition amid push for medicine access
2+ week, 3+ day ago (132+ words) PharmaDispatch Sandoz earns workplace recognition amid push for medicine access Sandoz Australia and New Zealand has been named among Australia’s Top 100 Best Workplaces for 2026, ranking 15th in the medium-sized business category and standing as the only pharmaceutical company included in that…...
Entropy takes TRP-8803 to the US in head-to-head depression trial - BioPharmaDispatch
2+ week, 5+ day ago (143+ words) Entropy takes TRP-8803 to the US in head-to-head depression trial PharmaDispatch Entropy takes TRP-8803 to the US in head-to-head depression trial Entropy Neurodynamics has signed an agreement with the University of California, San Francisco, to develop a US Phase 2 trial…...
Argent BioPharma takes CannEpil into US veterinary regulatory process
2+ week, 5+ day ago (126+ words) PharmaDispatch Argent BioPharma takes CannEpil into US veterinary regulatory process Chairman Roby Zomer said the development marked the program’s transition from a commercial agreement into formal engagement with the FDA’s veterinary medicines division. … Australian study finds maternal RSV vaccination offers…...
Professor Brandon Wainwright appointed to lead QIMR Berghofer
2+ week, 5+ day ago (118+ words) PharmaDispatch Professor Brandon Wainwright appointed to lead QIMR Berghofer QIMR Berghofer, one of Australia's leading medical research institutions, has appointed internationally recognised geneticist Professor Brandon Wainwright AM as its next Director and Chief Executive Officer. … Australian study finds maternal RSV…...
Wesfarmers Health evolves its loyalty program with new Pulse Rewards
3+ week, 5+ day ago (140+ words) PharmaDispatch Wesfarmers Health evolves its loyalty program with new Pulse Rewards Wesfarmers Health has launched Pulse Rewards, bringing its pharmacy, health, and beauty brands together under a single loyalty platform that rewards customers across a broader range of everyday health…...